NAX-035

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameNAX-035

Drug Alias NameBerberine DerivativeNAX-035

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionThymidylate synthase inhibitors

TargetsThymidylate synthase

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryItaly

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNaxospharma SRL

China Registration ClassN/A

Active CompaniesNaxospharma SRL

Inactive CompaniesN/A

Active IndicationsBreast Neoplasms

Inactive IndicationsN/A

ATC CodeN/A